Cancer mitochondria-targeted luminoptogenetics (mLumiOpto) to treat GBM and metastatic cancers
TS-075179 — Problem
Mitochondria is a promising target for cancer treatment. However, current strategies to specifically and effectively destroy cancer mitochondria in vivo are limited.
Solution
Applications
Competitive Advantages
Seeking Opportunities for Licensing and collaboration
- College: College of Engineering (COE)
- Inventors: Liu, Xiaoguang "Margaret"; Zhou, Lufang
- Licensing Officer: Schworer, Adam
